Neutralizing Monoclonal Antibodies to Fight HIV-1: On the Threshold of Success

被引:12
作者
Pablo Jaworski, Juan [1 ,2 ]
Vendrell, Alejandrina [3 ]
Matias Chiavenna, Sebastian [4 ]
机构
[1] Natl Sci & Tech Res Council, Buenos Aires, DF, Argentina
[2] Natl Inst Agr Technol, Inst Virol, Buenos Aires, DF, Argentina
[3] Univ Buenos Aires, Pharmacol & Bot Study Ctr, Sch Med, Buenos Aires, DF, Argentina
[4] Ferrer Adv Biotherapeut, Barcelona, Spain
关键词
human immunodeficiency virus; neutralizing antibodies; treatment; prophylaxis; reservoir; vaccine; HUMAN-IMMUNODEFICIENCY-VIRUS; T-CELL DEPLETION; PROXIMAL EXTERNAL REGION; MUCOSAL SHIV CHALLENGE; N-GLYCAN RECOGNITION; B-CELLS; POTENT NEUTRALIZATION; BISPECIFIC ANTIBODIES; PASSIVE TRANSFER; CONFORMATIONAL EPITOPE;
D O I
10.3389/fimmu.2016.00661
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Anti-human immunodeficiency virus type-1 (anti-HIV-1) neutralizing monoclonal antibodies are broadening the spectrum of pre-and post-exposure treatment against HIV-1. A better understanding of how these antibodies develop and interact with particular regions of the viral envelope protein is guiding a more rational structure-based immunogen design. The aim of this article is to review the most recent advances in the field, from the development of these particular antibodies during natural HIV-1 infection, to their role preventing infection, boosting endogenous immune responses and clearing both free viral particles and persistently infected cells.
引用
收藏
页数:11
相关论文
共 147 条
[1]   Impact of Multi-Targeted Antiretroviral Treatment on Gut T Cell Depletion and HIV Reservoir Seeding during Acute HIV Infection [J].
Ananworanich, Jintanat ;
Schuetz, Alexandra ;
Vandergeeten, Claire ;
Sereti, Irini ;
de Souza, Mark ;
Rerknimitr, Rungsun ;
Dewar, Robin ;
Marovich, Mary ;
van Griensven, Frits ;
Sekaly, Rafick ;
Pinyakorn, Suteeraporn ;
Phanuphak, Nittaya ;
Trichavaroj, Rapee ;
Rutvisuttinunt, Wiriya ;
Chomchey, Nitiya ;
Paris, Robert ;
Peel, Sheila ;
Valcour, Victor ;
Maldarelli, Frank ;
Chomont, Nicolas ;
Michael, Nelson ;
Phanuphak, Praphan ;
Kim, Jerome H. .
PLOS ONE, 2012, 7 (03)
[2]   Immediate antiviral therapy appears to restrict resting CD4+ cell HIV-1 infection without accelerating the decay of latent infection [J].
Archin, Nancie M. ;
Vaidya, Naveen K. ;
Kuruc, JoAnn D. ;
Liberty, Abigail L. ;
Wiegand, Ann ;
Kearney, Mary F. ;
Cohen, Myron S. ;
Coffin, John M. ;
Bosch, Ronald J. ;
Gay, Cynthia L. ;
Eron, Joseph J. ;
Margolis, David M. ;
Perelson, Alan S. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (24) :9523-9528
[3]   Passive immunization with the anti-HIV-1 human monoclonal antibody (hMAb) 4E10 and the hMAb combination 4E10/2F5/2G12 [J].
Armbruster, C ;
Stiegler, GM ;
Vcelar, BA ;
Jäger, W ;
Köller, U ;
Jilch, R ;
Ammann, CG ;
Pruenster, M ;
Stoiber, H ;
Katinger, HWD .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 54 (05) :915-920
[4]   Bispecific Antibodies Targeting Different Epitopes on the HIV-1 Envelope Exhibit Broad and Potent Neutralization [J].
Asokan, M. ;
Rudicell, R. S. ;
Louder, M. ;
McKee, K. ;
O'Dell, S. ;
Stewart-Jones, G. ;
Wang, K. ;
Xu, L. ;
Chen, X. ;
Choe, M. ;
Chuang, G. ;
Georgiev, I. S. ;
Joyce, M. G. ;
Kirys, T. ;
Ko, S. ;
Pegu, A. ;
Shi, W. ;
Todd, J. P. ;
Yang, Z. ;
Bailer, R. T. ;
Rao, S. ;
Kwong, P. D. ;
Nabel, G. J. ;
Mascola, J. R. .
JOURNAL OF VIROLOGY, 2015, 89 (24) :12501-12512
[5]   Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection [J].
Baba, TW ;
Liska, V ;
Hofmann-Lehmann, R ;
Vlasak, J ;
Xu, WD ;
Ayehunie, S ;
Cavacini, LA ;
Posner, MR ;
Katinger, H ;
Stiegler, G ;
Bernacky, BJ ;
Rizvi, TA ;
Schmidt, R ;
Hill, LR ;
Keeling, ME ;
Lu, YC ;
Wright, JE ;
Chou, TC ;
Ruprecht, RM .
NATURE MEDICINE, 2000, 6 (02) :200-206
[6]   Vectored immunoprophylaxis protects humanized mice from mucosal HIV transmission [J].
Balazs, Alejandro B. ;
Ouyang, Yong ;
Hong, Christin M. ;
Chen, Joyce ;
Nguyen, Steven M. ;
Rao, Dinesh S. ;
An, Dong Sung ;
Baltimore, David .
NATURE MEDICINE, 2014, 20 (03) :296-300
[7]   Antibody-based protection against HIV infection by vectored immunoprophylaxis [J].
Balazs, Alejandro B. ;
Chen, Joyce ;
Hong, Christin M. ;
Rao, Dinesh S. ;
Yang, Lili ;
Baltimore, David .
NATURE, 2012, 481 (7379) :81-U88
[8]   Sustained antibody-dependent cell-mediated cytotoxicity (ADCC) in SIV-infected macaques correlates with delayed progression to AIDS [J].
Banks, ND ;
Kinsey, N ;
Clements, J ;
Hildreth, JEK .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2002, 18 (16) :1197-1205
[9]   Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption [J].
Bar, K. J. ;
Sneller, M. C. ;
Harrison, L. J. ;
Justement, J. S. ;
Overton, E. T. ;
Petrone, M. E. ;
Salantes, D. B. ;
Seamon, C. A. ;
Scheinfeld, B. ;
Kwan, R. W. ;
Learn, G. H. ;
Proschan, M. A. ;
Kreider, E. F. ;
Blazkova, J. ;
Bardsley, M. ;
Refsland, E. W. ;
Messer, M. ;
Clarridge, K. E. ;
Tustin, N. B. ;
Madden, P. J. ;
Oden, K. S. ;
O'Dell, S. J. ;
Jarocki, B. ;
Shiakolas, A. R. ;
Tressler, R. L. ;
Doria-Rose, N. A. ;
Bailer, R. T. ;
Ledgerwood, J. E. ;
Capparelli, E. V. ;
Lynch, R. M. ;
Graham, B. S. ;
Moir, S. ;
Koup, R. A. ;
Mascola, J. R. ;
Hoxie, J. A. ;
Fauci, A. S. ;
Tebas, P. ;
Chun, T-W .
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (21) :2037-2050
[10]   Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys [J].
Barouch, Dan H. ;
Whitney, James B. ;
Moldt, Brian ;
Klein, Florian ;
Oliveira, Thiago Y. ;
Liu, Jinyan ;
Stephenson, Kathryn E. ;
Chang, Hui-Wen ;
Shekhar, Karthik ;
Gupta, Sanjana ;
Nkolola, Joseph P. ;
Seaman, Michael S. ;
Smith, Kaitlin M. ;
Borducchi, Erica N. ;
Cabral, Crystal ;
Smith, Jeffrey Y. ;
Blackmore, Stephen ;
Sanisetty, Srisowmya ;
Perry, James R. ;
Beck, Matthew ;
Lewis, Mark G. ;
Rinaldi, William ;
Chakraborty, Arup K. ;
Poignard, Pascal ;
Nussenzweig, Michel C. ;
Burton, Dennis R. .
NATURE, 2013, 503 (7475) :224-+